Drug delivery specialist aims to be key player as medicine turns to cell technology and personalised medicine to tackle cancers

Waterford Distillery founder Mark Reynier aims to produce the best single malt

Avectas has now raised $20m as it looks to unlock potential of personalised medicine

July, August and September winners of awards in association with KPMG

The last 12 months proved to be another year of mixed fortunes in corporate Ireland

Adapt agreed a $635m deal in August that will see it taken over by Emergen

Entrepreneur might turn attention to Maynooth University cancer therapy spinout

US opioid crisis helped growth of overdose rescue drug marketed by Adapt Pharma

Adapt Pharma’s Narcan spray used in the front line of opioid crisis in United States

Irish drug group reports 27% rise in sales but profit slips and supply disruptions remain

Drug firm with Athlone manufacturing plant seen as second fastest-growing US share

Company accounts show Waterford Distillers recorded €564,214 loss last year

Jazz by name and jazzy by metaphor, the Irish firm is now a muscular player in the pharmaceutical world. ‘We specialise in devastating diseases’ says founder Bruce Cozadd

Profector Life Sciences has scientific instruments business selling devices that allow researchers to deliver molecules to cultured cells